Herein we give a theoretical study of the hydrolysis processes of a novel anticancer drug trans-[PtCl 2 (3-pico)(ipa)] (3-pico=3-methylpyridine, ipa=isopropylamine). Two different models, model 1 relative to isolated reactant/product (R/P, wherein R=platinum complex+H 2 O, P=platinum complex+Cl − ) and model 2 relative to reactant complex/product complex (RC/PC, wherein RC=(platinum complex)(H 2 O), PC=(platinum complex)(Cl − ) are employed and the geometric structures are optimized at the B3LYP level of DFT method. It is found that the processes of the reactions follow the established theory for ligand substitution in square planar complexes; the geometries of the transition states (TS) agree with the previous related work and all of the reactions are endothermic. The effects originating from the inclusion of the attacking water/released chloride into the second coordination shell of platinum in RC/PC play an important role in the thermodynamic and kinetic profiles of the reactions, that is, the barrier heights of the reactions of model 2 are increased by ∼26.3 and ∼23.8 kJ/mol for step1 and step2 respectively, and the endothermicity is considerably decreased by ∼420.5 and ∼771.2 kJ/mol compared to model 1 in the gas phase. The consideration of the bulk solvation effects increase the barrier heights for both steps of model 1 by ∼27.6 and ∼6.7 kJ/mol respectively, whereas it reduces the barrier heights by ∼7.9 and ∼29.3 kJ/mol for model 2. The reaction energies are all decreased, especially for model 1, indicating more stable complexes solvated in the bulk aqueous solution than in the gas phase. Additionally, to get an accurate energy picture of the title complex, the relative free energies derived from the DFT-SCRF (density functional theory self-consistent field) calculations are compared with the relative total energies. The results are that activation energies rise for the first hydrolysis and fall for the second hydrolysis for all the systems, and for all the systems, the barrier height of the second hydrolysis is always higher than that of the first step. The rate constants indicate that transplatin analogue is kinetically comparable to cisplatin and its analogue in the hydrolysis process.
I. INTRODUCTION
The ability of square-planar platinum (II) complexes to covalently bind to biological target DNA and distort its structure gives hope of subsistence to many cancersuffering patients. The currently most widely used anticancer drug cisplatin has this ability, which makes it an efficient agent, yet its clinical success is weakened by the ability of tumor cells to acquire resistance to it and its inefficacy to several species of tumors [1, 2] . Additionally, although cisplatin indeed distorts DNA and triggers cellular processes that lead to the death of cancer cells [3] , it has a lot of side effects, such as queasiness, vomiting and neural disease [2] . Also, cisplatin is badly soluble, which leads to poor intestinal absorption and hence leads to the requirement of intravenous administration. Thus better activity, less side effect, and better cellular uptake have become crucial factors in the search for new anticancer drugs.
Since the 1990s several classes of transplatin ana- * Author to whom correspondence should be addressed. E-mail: tlzhou@jnu.edu.cn logues (or trans platinum) with planar heterocyclic ammine or bulky aliphatic ammine ligands have been found to display a lot of DNA binding properties [2, [4] [5] [6] [7] [8] [9] and several species are active to some tumors that are either sensitive or resistant to cisplatin. The preparation, cytotoxicity and the DNA binding properties of trans platinum containing pyridine, piperazine, piperidine and aliphatic ammine ligands have already been reported [10, 11] . This series of drugs can overcome cisplatin resistance of some cancer cells.
Although so many papers about the anticancer activity and properties of trans platinum have been reported, so far comprehensive theoretical description of the hydrolysis of this series of agents, which is believed to be the key step before the drug reaches its biological target DNA in the cell, are scarce. In this work, a theoretical study of the hydrolysis of a novel trans platinum anticancer drug is reported.
We select 3-methylpyridine (3-pico) and isopropylamine (ipa) as ligands because we need a soluble, cationic (after the hydrolysis process) trans platinum complex. Established theory says that hydrolysis plays a key role in the activation of platinum-containing anticancer drugs [12] [13] [14] , in which chlorides are substituted by water molecules step by step to form active monoaqua and diaqua species, so we give the fully optimized structures of stationary states along the nucleophilic substitution pathway. T rans Pt remains intact due to the high chloride concentration in the blood [15] , yet it is hydrolyzed according to the probable reactions modes, as shown in Fig.1 , after it enters the cells (TS in model 1 is exactly the same as the corresponding TS in model 2 (vide infra)).
As mentioned above, two patterns of models are employed in this work, namely, model 1 related to R/P and model 2 related to RC/PC. Model 2 is compared with model 1 in order to observe the effect originating from the inclusion of the attacking water/released chloride into RC/PC on the activation energies. Single-point energies are calculated on the basis of the optimized structures; solvation effects are taken into account by means of single-point calculations on all stationary structures to show accurate pictures in the aqueous phase. Both of the geometric and energy profiles are discussed.
II. COMPUTATIONAL DETAILS
Firstly, all of the geometric optimizations are performed in the gas phase at 298 K using the Becke threeparameter hybrid exchange functional (B3) [15] and the Lee, Yang, and Parr correlation functional (LYP) [16] of the density functional theory (DFT) [17] method, with the Lanl2DZ [18] [19] [20] effective core potential basis set for Pt atom while with the 6-31G (d,p) basis set for other atoms. The optimizations are followed and verified by the vibration frequency calculations that are carried out using the same level with the former. Transition states are conformed by intrinsic reaction coordinate (IRC) calculations. Thermal energy contributions are extracted from the frequency calculations to obtain the respective Gibbs free energies at 298 K. Single-point (sp) energy calculations are performed at the B3LYP level with the basis set of Lanl2DZ for Pt and 6-311++G (2d,2p) for other atoms on the structures optimized at the B3LYP/(LanL2DZ+6-31G(d,p)) level. Solvation effects are taken into account by means of sp calculations on all stationary structures using the iso-electric focusing polarized continuum model (IEF-PCM) solution model [21] [22] [23] . The dielectric constant of water (ε=78.39) is used to approximate the bulk effects of solution.
In order to get a clear illustration of the kinetic facet of the reactions, the rate constants K(T ) are calculated within the transition state theory according to the formalism proposed by Eyring [24] as follows: wherein k B is the Boltzmann constant, T the absolute temperature, and h the Planck's constant. ∆G is the activation free energy including solvation and zero point energy (ZPE) corrections for each step. The standard concentration (c o =1 mol/L) is considered. All calculations are performed using the Gaussian03 program package [25] .
III. RESULTS AND DISCUSSION

A. Geometric profiles of the reactions of trans Pt
The fully optimized geometric structures with the hydrogen bonds marked with dashed lines are shown in Fig.2 . The present work, based on the analysis of R-TS-P and RC-TS-PC stepwise hydrolysis process shows that the reactions undergo the same TSs, (i.e., in R1-TS1-P1 and RC1-TS1 -PC1 reactions, TS1 is exactly the same as TS1', so both are labeled as TS1) which can be explained by the same structures and energies of TSs. Key geometric parameters along the pathway for the partaking species in the two steps are also shown in Fig.2 , which follow the established change trend of the nucleophilic substitution reaction, i.e., the distance between the entering ligand (water molecule) and Pt atom decreases from R/RC via TS to P/PC till the water is completely dative-bonded to Pt and the distance between the leaving ligand (chloride) and Pt atom is elongated along the reaction pathway till the chloride is thoroughly released.
Variations of Pt−O E (E=entering) and Pt−Cl L (L=leaving) bond length during the hydrolysis in the gas phase for the three states (R/RC, TS, P/PC) of the two models are displayed using straight lines in Fig.3 according to the values in Fig.2 for clarity of illustration. Structures for R/RC, TS, and P/PC are displayed in Fig.1 . We can see that differences between the two models are that in R/P the attacking water/released chloride is so far from the platinum complex that no interactions exist between them in model 1 whereas in RC/PC the water/chloride is located in the second coordination shell of platinum [26] in model 2, with the Pt−O E distance of 3.39 and 4.05Å for RC1 and RC2, and Pt−Cl L distance of 3.93 and 4.05Å for PC1 and PC2. Since there are so many similar geometric characteristics between model 1 and model 2, only the prominent features will be discussed.
Observation of the structural characters in model 1 reveals that trans Pt has a square-planar geometry around the Pt-atom. The bond lengths of Pt−Cl L and Pt−Cl R (R=remaining) are 2.39 and 2.39Å, and those of Pt−N ipa and Pt−N 3-pico are 2.09 and 2.06Å respectively, with the ∠Cl L −Pt−Cl R and ∠N ipa −Pt−N 3-pico angles of 174.8
• and 178.8
• , respectively. The characteristic features of the TSs agree with the previous patterns established for cisplatin and its analogues [13] [14] [15] , with the five coordinates around Pt atom forming a five-coordinate trigonal-bipyramidal(TBP)-like structure and the leaving ligand, entering ligand and the remaining ligand together with Pt atom forming the equatorial plane. The transition state of step 1 has an imaginary frequency of −145i cm −1 , wherein the leaving chloride ligand, the entering water ligand, and the remaining chloride ligand together with the Pt center forms the equatorial plane. The angle between the axial ligands is 174.5
• and the axis is not absolutely vertical with the equatorial plane, indicating a somewhat skewed trigonal bipyramidal structure. The breaking Pt−Cl L bond is elongated from 2.39Å in R1-1 to 2.88Å in TS1, with the forming Pt−O E bond of 2.52Å and the remaining Pt−Cl R bond length of 2.36Å compared to 2.39Å in R1-1. In the mono aquated species trans Pt + , the chloride is completely released and O E -atom is fully bonded to Pt center, with the Pt−O E bond length of 2.20Å. Also, the Pt−Cl R bond length is shortened from 2.39Å in R1-1 to 2.31Å, which is unexpected. The Pt−Cl R bond length should be elongated according to the trans effect resulting from the stronger electrondonating properties of the trans-positioned water than chloride. As for the second hydrolysis, the breaking Pt−Cl L bond length is elongated from 2.31Å in R2-1 to 2.79Å in TS2 and the forming Pt−O E bond length is shortened from 2.29Å in TS2 to 2.09Å in the diaquated species P2-1. The TS2 structure is also a bit skewed, with the angle between the axially oriented ligands of 175.6
• . The change trend of the bond lengths for RC-TS-PC in model 2 is similar to that of model 1 and thus will not be given detailed discussion since the illustrations are available in Fig.3 .
In spite of the similar bond change trends for the two models, significant differences are observed between R/P and corresponding RC/PC for both of the first and second hydrolysis because of the hydrogen bonds formed in RC/PC.
From Fig.2 we can see that in RC1 the entering water is hydrogen-bonded to the ipa ligand, with the leaving chloride and the water acting as the hydrogen-acceptor and donor respectively. The O E · · · H bond length is 1.87Å and the Cl L · · · H bond length is 2.27Å. As for PC1, the released chloride is hydrogen-bonded to the substituted water and ipa ligand, the chloride acting as the hydrogen-acceptor, with the hydrogen-bond lengths of 1.79 and 2.17Å respectively.
The patterns of the hydrogen bonds in RC2 are similar to that in RC1, however, with a shorter O E · · · H(ipa) hydrogen bond length (1.79Å) and a much longer Cl L · · · H bond length (2.51Å). This interaction is a pretty weak one since the two hydrogen atoms of the entering water display approximate bond lengths (1.965 and 1.970Å). Hydrogen bond patterns in PC2 are also similar to that in PC1, with the Cl L · · · H (water) hydrogen bond length of 1.38Å and the Cl L · · · H (ipa) bond length of 2.28Å. Proton transfers are observed in both of PC1 and PC2.
Hydrogen bonds, as is well known, play an important role in the structures and stabilization energies of the complexes. For instance, obvious differences of geometric structures can be found between RC/PC and corresponding R/P. Comparing RC1/RC2 with R1-1/R2-1, we can find that the Pt-leaving ligand distances in RC are elongated for both of the first and second hydrolysis by about ∼0.02 and ∼0.01Å respectively, and the Pt-remaining ligand distances are shortened for both steps by about ∼0.01Å. As for the comparison of PC1/PC2 with P1-1/P2-1, it suggests that the Pt-O E bond lengths are shortened by ∼0.08/0.09Å in PC1/PC2. Pt−Cl R /Pt−O (1st substituted water) in PC1/PC2 are elongated by ∼0.04/∼0.09Å compared to P1-1/P2-1. As mentioned above, these distinctions of the bond lengths are mainly caused by the hydrogen bonds. For example, in PCs, the hydrogen bonding between the released chloride and the substituted water contributes to the enhancement of the electron-donating properties of the water-oxygen atom and thus shortens the Pt-O bond compared to isolated products.
Comparing TS1 with TS2, the equatorial planar angle of entering ligand-Pt-leaving ligand (O−Pt−Cl) in TS2 is lager than TS1, with 68.6
• compared to 65.5
• , indicating a higher steric repulsion. A weak hydrogen bond is formed between the entering water and leaving chloride, 2.06Å for TS1s and 2.08Å for TS2s.
B. Energy profiles of the hydrolysis reactions of trans Pt
In order to quantitatively evaluate the hydrolysis behaviors on the basis of electronic properties, various energy terms including the thermal effects at 298.15 K are calculated and the relative ZPE correction, thermal-corrected relative energies/enthalpies/free energies as well as the single-point energies in both of gas and aqueous phase are summarized and listed in Table I . For the sake of a clear illustration of the energy change trends, the relative energies ∆E sp/ZPE (g), ∆E tot/ZPE (aq), ∆G ZPE (aq) corresponding to the two models are shown in Figs. 4, 5, and 6, while other relative energy terms for each state are listed in and the ZPE-corrected energies are obtained as follows:
where energies of R are set to 0 and others are relative energies to it. The ZPE-corrected energies calculated in the gas phase for both steps of model 1 and model 2 are shown in Fig.4 , including R, RC, TS, PC and P, wherein several considerable features can be found for the systems. It can be seen from Fig.4 that energy change trend of model 1 and model 2 reactions follows the established theory for substitution reactions, with the R climbing up to TS, which afterward continuously clambers and increases its energy until it gives rise to the hydrolysis product; the RC climbs up to TS and then the TS releases its energy to generate the PC. Both of the first reactions of model 1 and model 2 are endothermic, by 494.5 and 74.0 kJ/mol with the large basis set of 6-311++G (2d,2p). The reduced endothermicity of model 2 compared to model 1 is due to the inclusion of the attacking water and the released chloride into the second coordination shell of platinum, mainly because the hydrogen bonds formed between the Pt moiety and the chloride can enhance the stability of PC. However, these effects on the barrier heights are just the opposite, with the barrier height increased by ∼26.3 kJ/mol for model 2 compared to model 1. One can easily find that the RC is more stable than R (set to 0) by ∼26.3 kJ/mol because of the hydrogen bonds formed in RC. And it is due to the more stable RC compared to R that the activation energy of model 2 is higher than model 1 since they have to climb up to the TS with the same stabi- lization energy as mentioned above. The comparison of the second reaction of model 1 with model 2 is similar to that of the first reaction, with the endothermicity difference of ∼771.2 kJ/mol (75.6 kJ/mol for model 2 and 846.9 kJ/mol for model 1) and barrier height difference of ∼23.8 kJ/mol (137.5 kJ/mol for model 2 to 113.7 kJ/mol for model 1), and will not be given indepth discussion since the associated values are available in Fig.4 .
For the comparison of the first reaction of model 1 with model 2 in the aqueous phase (see Fig.5 ), it follows that RC is less stable than R by ∼9.2 kJ/mol, and subsequently the barrier height of model 2 is lower than that of model 1 by ∼9.2 kJ/mol. Moreover, PC (27.2 kJ/mol) is more stable than P (50.2 kJ/mol), which is out of our expectation since a fully solvated chlorine anionic is expected to be more stable than a chlorine in the second coordination shell of the platinum complex. Yet for the second reaction, PC and RC (81.9 and 69.8 kJ/mol) is less stable than the corresponding P and R (12.1 and 0 kJ/mol), leading to a lower barrier height of 101.6 kJ/mol for model 2.
C. Solvent effect on the energy properties of trans Pt
The effect of the addition of the extra water molecule and chlorine anion into the platinum complex has been discussed in the previous section and in this part we will give the description and explanation of the effect of the aqueous solution. Figure 5 displays the ZPE-corrected total energies calculated with the density functional theory self-consistent field in aqueous solution. Comparing the energies in the gas phase and aqueous phase displayed in Fig.4 and 5 respectively, significant differences can be found. The endothermicity of the first reaction of model 1 is largely decreased from 494.5 kJ/mol to 50.2 kJ/mol in the solution phase where the solvation effect is included. This is to be expected since P is more stable when the chlorine anionic is fully solvated in the bulk solution. Yet this effect on the activation energies is just inverted, with the barrier height increased by ∼27.6 kJ/mol. As for model 2, a decreased endothermicity (18.0 kJ/mol compared to 74.0 kJ/mol) and activation energy (95.7 kJ/mol compared to 103.7 kJ/mol) in aqueous are present for the first reaction, indicating the model 2 reaction favors the aqueous phase. Turning to the second reaction, the inclusion of the solvation effect similarly decreases the endothermicity of model 1 (69.8 kJ/mol compared to 846.9 kJ/mol), yet increases the barrier height by ∼6.9 kJ/mol. When model 2 is considered, the endothermicity falls from 75.6 kJ/mol to 57.7 kJ/mol and the barrier height falls from 130.8 kJ/mol to 101.6 kJ/mol.
Entropic corrections to the ∆E tot/ZPE (aq) are displayed in Fig.6 , labeled as ∆G ZPE (aq), which slightly decrease the barrier height by ∼2.5 kJ/mol for the first hydrolysis whereas they increase that by ∼5.8 kJ/mol for the second hydrolysis for model 1, and for model 2 it slightly decreases the activation energies by ∼0.4 kJ/mol (95.3 kJ/mol compared to 95.7 kJ/mol) while increasing that by ∼12.5 kJ/mol (114.1 kJ/mol compared to 101.6 kJ/mol) for step 1 and step 2 respectively. Comparing the first hydrolysis with the second one, the barrier height of the latter is always higher for all the systems.
D. Rate constant
Using the calculated Gibbs free energy barriers, the rate constants are evaluated. For different steps of R1→P1, R2→P2, RC1→PC1, and RC2→PC2, the rate constants are 5.8×10 −3 , 5.6×10 −6 , 0.1, and 5.0×10
−5 L/(mol·s). In Ref. [12] , the rate constants of RC1→PC1 and RC2→PC2 were 1.1×10 −2 and 1.1×10 −8 L/(mol·s). In Ref. [14] , the rate constants of RC1→PC1 and RC2→PC2 were 2.1×10 −3 and 3.6×10 −5 L/(mol·s). The values indicate that: (i) reactions in model 2 are much quicker than in model 1; (ii) the second step is slower than the first step, indicating more difficulties to remove a chloride molecule from the monoaquated platinum complex; (iii) transplatin analogue (the title complex) hydrolyzes more quickly than cisplatin in both of the two steps and more quickly than cisplatin analogue in the first step while slightly more slowly in the second step. The results indicate that transplatin analogue is kinetically comparable to cisplatin or its analogue in the hydrolysis process.
IV. CONCLUSION
In this work we have employed hybrid DFT methods to investigate the hydrolysis processes of the transplatin analogue. It is found that the addition of the water molecule/chloride into the second coordination shell of platinum complex in RC/PC plays a crucial role in the geometric and energy profiles. The geometric differences between model 1 and model 2 reflect the changes of the electronic-donating ability of the ligands caused by the hydrogen bonds formed between the Pt moiety and the water/chloride in model 2. Additionally, the hydrogen bonds stabilize the product complexes in model 2 and thus decrease the endothermicity in the gas phase. However, the activation energies are increased for model 2 reactions because the RCs have lower stability energies compared to Rs yet they process via a similar transition state that possesses the same stability energy. When the effects of the bulk solution are considered, the barrier heights are raised for model 1 in both step 1 and step 2, and interestingly, slightly reduced for both steps of model 2. Moreover, in the aqueous solution where the RCs are less stable than Rs, the barrier heights are lower for model 2 reactions, just opposite to the gas phase. For all the systems, the barrier height of the second hydrolysis is always higher than that of the first one. By comparing the ∆G ZPE (aq) with the ∆E tot/ZPE (aq), it is found that the entropic effects raise the activation energies for the first hydrolysis and reduce that for the second hydrolysis for all the systems. Lastly, the rate constants indicate that transplatin analogue is comparable to cisplatin or its analogue in the hydrolysis process.
